Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Ascletis Pharma, Inc. ( (HK:1672) ) has issued an announcement.
Ascletis Pharma Inc. has announced the book closure period for its extraordinary general meeting (EGM) scheduled on February 3, 2025. The register of members will be closed for share transfers from January 28 to February 3, 2025. This meeting is significant for shareholders as it will determine their entitlements to attend and vote. Additional details regarding the EGM, including the circular and proxy forms, will be provided in due course.
More about Ascletis Pharma, Inc.
Ascletis Pharma Inc. is a biotechnology company incorporated in the Cayman Islands, with operations in Hangzhou, China. The company focuses on developing and commercializing innovative therapies for viral, cancer, and liver diseases.
YTD Price Performance: 5.65%
Average Trading Volume: 2,379,310
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: HK$2.88B
Find detailed analytics on 1672 stock on TipRanks’ Stock Analysis page.